Pharma & Healthcare
Global Recombinant Human Thrombin (rhThrombin) Market Research Report 2025
- Aug 11, 25
- ID: 441406
- Pages: 70
- Figures: 73
- Views: 4
Report Scope
This report aims to provide a comprehensive presentation of the global market for Recombinant Human Thrombin (rhThrombin), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Human Thrombin (rhThrombin).
The Recombinant Human Thrombin (rhThrombin) market size, estimations, and forecasts are provided in terms of sales volume (K Vitals) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Recombinant Human Thrombin (rhThrombin) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Human Thrombin (rhThrombin) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Baxter
Suzhou Zelgen Biopharmaceuticals
Segment by Type
5,000 IU/Vital
20,000 IU/Vial
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Recombinant Human Thrombin (rhThrombin) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Recombinant Human Thrombin (rhThrombin) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
This report aims to provide a comprehensive presentation of the global market for Recombinant Human Thrombin (rhThrombin), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Human Thrombin (rhThrombin).
The Recombinant Human Thrombin (rhThrombin) market size, estimations, and forecasts are provided in terms of sales volume (K Vitals) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Recombinant Human Thrombin (rhThrombin) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Human Thrombin (rhThrombin) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Baxter
Suzhou Zelgen Biopharmaceuticals
Segment by Type
5,000 IU/Vital
20,000 IU/Vial
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Recombinant Human Thrombin (rhThrombin) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Recombinant Human Thrombin (rhThrombin) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Recombinant Human Thrombin (rhThrombin) Market Overview
1.1 Product Definition
1.2 Recombinant Human Thrombin (rhThrombin) by Type
1.2.1 Global Recombinant Human Thrombin (rhThrombin) Market Value Comparison by Type (2024 VS 2031)
1.2.2 5,000 IU/Vital
1.2.3 20,000 IU/Vial
1.3 Recombinant Human Thrombin (rhThrombin) by Application
1.3.1 Global Recombinant Human Thrombin (rhThrombin) Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Recombinant Human Thrombin (rhThrombin) Market Size Estimates and Forecasts
1.4.1 Global Recombinant Human Thrombin (rhThrombin) Revenue 2020-2031
1.4.2 Global Recombinant Human Thrombin (rhThrombin) Sales 2020-2031
1.4.3 Global Recombinant Human Thrombin (rhThrombin) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Recombinant Human Thrombin (rhThrombin) Market Competition by Manufacturers
2.1 Global Recombinant Human Thrombin (rhThrombin) Sales Market Share by Manufacturers (2020-2025)
2.2 Global Recombinant Human Thrombin (rhThrombin) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Recombinant Human Thrombin (rhThrombin) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Recombinant Human Thrombin (rhThrombin), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Recombinant Human Thrombin (rhThrombin), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Recombinant Human Thrombin (rhThrombin), Product Type & Application
2.7 Global Key Manufacturers of Recombinant Human Thrombin (rhThrombin), Date of Enter into This Industry
2.8 Global Recombinant Human Thrombin (rhThrombin) Market Competitive Situation and Trends
2.8.1 Global Recombinant Human Thrombin (rhThrombin) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Recombinant Human Thrombin (rhThrombin) Players Market Share by Revenue
2.8.3 Global Recombinant Human Thrombin (rhThrombin) Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Recombinant Human Thrombin (rhThrombin) Market Scenario by Region
3.1 Global Recombinant Human Thrombin (rhThrombin) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Recombinant Human Thrombin (rhThrombin) Sales by Region: 2020-2031
3.2.1 Global Recombinant Human Thrombin (rhThrombin) Sales by Region: 2020-2025
3.2.2 Global Recombinant Human Thrombin (rhThrombin) Sales by Region: 2026-2031
3.3 Global Recombinant Human Thrombin (rhThrombin) Revenue by Region: 2020-2031
3.3.1 Global Recombinant Human Thrombin (rhThrombin) Revenue by Region: 2020-2025
3.3.2 Global Recombinant Human Thrombin (rhThrombin) Revenue by Region: 2026-2031
3.4 North America Recombinant Human Thrombin (rhThrombin) Market Facts & Figures by Country
3.4.1 North America Recombinant Human Thrombin (rhThrombin) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Recombinant Human Thrombin (rhThrombin) Sales by Country (2020-2031)
3.4.3 North America Recombinant Human Thrombin (rhThrombin) Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Recombinant Human Thrombin (rhThrombin) Market Facts & Figures by Country
3.5.1 Europe Recombinant Human Thrombin (rhThrombin) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Recombinant Human Thrombin (rhThrombin) Sales by Country (2020-2031)
3.5.3 Europe Recombinant Human Thrombin (rhThrombin) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Recombinant Human Thrombin (rhThrombin) Market Facts & Figures by Region
3.6.1 Asia Pacific Recombinant Human Thrombin (rhThrombin) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Recombinant Human Thrombin (rhThrombin) Sales by Region (2020-2031)
3.6.3 Asia Pacific Recombinant Human Thrombin (rhThrombin) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Recombinant Human Thrombin (rhThrombin) Market Facts & Figures by Country
3.7.1 Latin America Recombinant Human Thrombin (rhThrombin) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Recombinant Human Thrombin (rhThrombin) Sales by Country (2020-2031)
3.7.3 Latin America Recombinant Human Thrombin (rhThrombin) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Recombinant Human Thrombin (rhThrombin) Market Facts & Figures by Country
3.8.1 Middle East and Africa Recombinant Human Thrombin (rhThrombin) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Recombinant Human Thrombin (rhThrombin) Sales by Country (2020-2031)
3.8.3 Middle East and Africa Recombinant Human Thrombin (rhThrombin) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Recombinant Human Thrombin (rhThrombin) Sales by Type (2020-2031)
4.1.1 Global Recombinant Human Thrombin (rhThrombin) Sales by Type (2020-2025)
4.1.2 Global Recombinant Human Thrombin (rhThrombin) Sales by Type (2026-2031)
4.1.3 Global Recombinant Human Thrombin (rhThrombin) Sales Market Share by Type (2020-2031)
4.2 Global Recombinant Human Thrombin (rhThrombin) Revenue by Type (2020-2031)
4.2.1 Global Recombinant Human Thrombin (rhThrombin) Revenue by Type (2020-2025)
4.2.2 Global Recombinant Human Thrombin (rhThrombin) Revenue by Type (2026-2031)
4.2.3 Global Recombinant Human Thrombin (rhThrombin) Revenue Market Share by Type (2020-2031)
4.3 Global Recombinant Human Thrombin (rhThrombin) Price by Type (2020-2031)
5 Segment by Application
5.1 Global Recombinant Human Thrombin (rhThrombin) Sales by Application (2020-2031)
5.1.1 Global Recombinant Human Thrombin (rhThrombin) Sales by Application (2020-2025)
5.1.2 Global Recombinant Human Thrombin (rhThrombin) Sales by Application (2026-2031)
5.1.3 Global Recombinant Human Thrombin (rhThrombin) Sales Market Share by Application (2020-2031)
5.2 Global Recombinant Human Thrombin (rhThrombin) Revenue by Application (2020-2031)
5.2.1 Global Recombinant Human Thrombin (rhThrombin) Revenue by Application (2020-2025)
5.2.2 Global Recombinant Human Thrombin (rhThrombin) Revenue by Application (2026-2031)
5.2.3 Global Recombinant Human Thrombin (rhThrombin) Revenue Market Share by Application (2020-2031)
5.3 Global Recombinant Human Thrombin (rhThrombin) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Baxter
6.1.1 Baxter Company Information
6.1.2 Baxter Description and Business Overview
6.1.3 Baxter Recombinant Human Thrombin (rhThrombin) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Baxter Recombinant Human Thrombin (rhThrombin) Product Portfolio
6.1.5 Baxter Recent Developments/Updates
6.2 Suzhou Zelgen Biopharmaceuticals
6.2.1 Suzhou Zelgen Biopharmaceuticals Company Information
6.2.2 Suzhou Zelgen Biopharmaceuticals Description and Business Overview
6.2.3 Suzhou Zelgen Biopharmaceuticals Recombinant Human Thrombin (rhThrombin) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Suzhou Zelgen Biopharmaceuticals Recombinant Human Thrombin (rhThrombin) Product Portfolio
6.2.5 Suzhou Zelgen Biopharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Recombinant Human Thrombin (rhThrombin) Industry Chain Analysis
7.2 Recombinant Human Thrombin (rhThrombin) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Recombinant Human Thrombin (rhThrombin) Production Mode & Process Analysis
7.4 Recombinant Human Thrombin (rhThrombin) Sales and Marketing
7.4.1 Recombinant Human Thrombin (rhThrombin) Sales Channels
7.4.2 Recombinant Human Thrombin (rhThrombin) Distributors
7.5 Recombinant Human Thrombin (rhThrombin) Customer Analysis
8 Recombinant Human Thrombin (rhThrombin) Market Dynamics
8.1 Recombinant Human Thrombin (rhThrombin) Industry Trends
8.2 Recombinant Human Thrombin (rhThrombin) Market Drivers
8.3 Recombinant Human Thrombin (rhThrombin) Market Challenges
8.4 Recombinant Human Thrombin (rhThrombin) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Recombinant Human Thrombin (rhThrombin) by Type
1.2.1 Global Recombinant Human Thrombin (rhThrombin) Market Value Comparison by Type (2024 VS 2031)
1.2.2 5,000 IU/Vital
1.2.3 20,000 IU/Vial
1.3 Recombinant Human Thrombin (rhThrombin) by Application
1.3.1 Global Recombinant Human Thrombin (rhThrombin) Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Recombinant Human Thrombin (rhThrombin) Market Size Estimates and Forecasts
1.4.1 Global Recombinant Human Thrombin (rhThrombin) Revenue 2020-2031
1.4.2 Global Recombinant Human Thrombin (rhThrombin) Sales 2020-2031
1.4.3 Global Recombinant Human Thrombin (rhThrombin) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Recombinant Human Thrombin (rhThrombin) Market Competition by Manufacturers
2.1 Global Recombinant Human Thrombin (rhThrombin) Sales Market Share by Manufacturers (2020-2025)
2.2 Global Recombinant Human Thrombin (rhThrombin) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Recombinant Human Thrombin (rhThrombin) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Recombinant Human Thrombin (rhThrombin), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Recombinant Human Thrombin (rhThrombin), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Recombinant Human Thrombin (rhThrombin), Product Type & Application
2.7 Global Key Manufacturers of Recombinant Human Thrombin (rhThrombin), Date of Enter into This Industry
2.8 Global Recombinant Human Thrombin (rhThrombin) Market Competitive Situation and Trends
2.8.1 Global Recombinant Human Thrombin (rhThrombin) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Recombinant Human Thrombin (rhThrombin) Players Market Share by Revenue
2.8.3 Global Recombinant Human Thrombin (rhThrombin) Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Recombinant Human Thrombin (rhThrombin) Market Scenario by Region
3.1 Global Recombinant Human Thrombin (rhThrombin) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Recombinant Human Thrombin (rhThrombin) Sales by Region: 2020-2031
3.2.1 Global Recombinant Human Thrombin (rhThrombin) Sales by Region: 2020-2025
3.2.2 Global Recombinant Human Thrombin (rhThrombin) Sales by Region: 2026-2031
3.3 Global Recombinant Human Thrombin (rhThrombin) Revenue by Region: 2020-2031
3.3.1 Global Recombinant Human Thrombin (rhThrombin) Revenue by Region: 2020-2025
3.3.2 Global Recombinant Human Thrombin (rhThrombin) Revenue by Region: 2026-2031
3.4 North America Recombinant Human Thrombin (rhThrombin) Market Facts & Figures by Country
3.4.1 North America Recombinant Human Thrombin (rhThrombin) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Recombinant Human Thrombin (rhThrombin) Sales by Country (2020-2031)
3.4.3 North America Recombinant Human Thrombin (rhThrombin) Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Recombinant Human Thrombin (rhThrombin) Market Facts & Figures by Country
3.5.1 Europe Recombinant Human Thrombin (rhThrombin) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Recombinant Human Thrombin (rhThrombin) Sales by Country (2020-2031)
3.5.3 Europe Recombinant Human Thrombin (rhThrombin) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Recombinant Human Thrombin (rhThrombin) Market Facts & Figures by Region
3.6.1 Asia Pacific Recombinant Human Thrombin (rhThrombin) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Recombinant Human Thrombin (rhThrombin) Sales by Region (2020-2031)
3.6.3 Asia Pacific Recombinant Human Thrombin (rhThrombin) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Recombinant Human Thrombin (rhThrombin) Market Facts & Figures by Country
3.7.1 Latin America Recombinant Human Thrombin (rhThrombin) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Recombinant Human Thrombin (rhThrombin) Sales by Country (2020-2031)
3.7.3 Latin America Recombinant Human Thrombin (rhThrombin) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Recombinant Human Thrombin (rhThrombin) Market Facts & Figures by Country
3.8.1 Middle East and Africa Recombinant Human Thrombin (rhThrombin) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Recombinant Human Thrombin (rhThrombin) Sales by Country (2020-2031)
3.8.3 Middle East and Africa Recombinant Human Thrombin (rhThrombin) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Recombinant Human Thrombin (rhThrombin) Sales by Type (2020-2031)
4.1.1 Global Recombinant Human Thrombin (rhThrombin) Sales by Type (2020-2025)
4.1.2 Global Recombinant Human Thrombin (rhThrombin) Sales by Type (2026-2031)
4.1.3 Global Recombinant Human Thrombin (rhThrombin) Sales Market Share by Type (2020-2031)
4.2 Global Recombinant Human Thrombin (rhThrombin) Revenue by Type (2020-2031)
4.2.1 Global Recombinant Human Thrombin (rhThrombin) Revenue by Type (2020-2025)
4.2.2 Global Recombinant Human Thrombin (rhThrombin) Revenue by Type (2026-2031)
4.2.3 Global Recombinant Human Thrombin (rhThrombin) Revenue Market Share by Type (2020-2031)
4.3 Global Recombinant Human Thrombin (rhThrombin) Price by Type (2020-2031)
5 Segment by Application
5.1 Global Recombinant Human Thrombin (rhThrombin) Sales by Application (2020-2031)
5.1.1 Global Recombinant Human Thrombin (rhThrombin) Sales by Application (2020-2025)
5.1.2 Global Recombinant Human Thrombin (rhThrombin) Sales by Application (2026-2031)
5.1.3 Global Recombinant Human Thrombin (rhThrombin) Sales Market Share by Application (2020-2031)
5.2 Global Recombinant Human Thrombin (rhThrombin) Revenue by Application (2020-2031)
5.2.1 Global Recombinant Human Thrombin (rhThrombin) Revenue by Application (2020-2025)
5.2.2 Global Recombinant Human Thrombin (rhThrombin) Revenue by Application (2026-2031)
5.2.3 Global Recombinant Human Thrombin (rhThrombin) Revenue Market Share by Application (2020-2031)
5.3 Global Recombinant Human Thrombin (rhThrombin) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Baxter
6.1.1 Baxter Company Information
6.1.2 Baxter Description and Business Overview
6.1.3 Baxter Recombinant Human Thrombin (rhThrombin) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Baxter Recombinant Human Thrombin (rhThrombin) Product Portfolio
6.1.5 Baxter Recent Developments/Updates
6.2 Suzhou Zelgen Biopharmaceuticals
6.2.1 Suzhou Zelgen Biopharmaceuticals Company Information
6.2.2 Suzhou Zelgen Biopharmaceuticals Description and Business Overview
6.2.3 Suzhou Zelgen Biopharmaceuticals Recombinant Human Thrombin (rhThrombin) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Suzhou Zelgen Biopharmaceuticals Recombinant Human Thrombin (rhThrombin) Product Portfolio
6.2.5 Suzhou Zelgen Biopharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Recombinant Human Thrombin (rhThrombin) Industry Chain Analysis
7.2 Recombinant Human Thrombin (rhThrombin) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Recombinant Human Thrombin (rhThrombin) Production Mode & Process Analysis
7.4 Recombinant Human Thrombin (rhThrombin) Sales and Marketing
7.4.1 Recombinant Human Thrombin (rhThrombin) Sales Channels
7.4.2 Recombinant Human Thrombin (rhThrombin) Distributors
7.5 Recombinant Human Thrombin (rhThrombin) Customer Analysis
8 Recombinant Human Thrombin (rhThrombin) Market Dynamics
8.1 Recombinant Human Thrombin (rhThrombin) Industry Trends
8.2 Recombinant Human Thrombin (rhThrombin) Market Drivers
8.3 Recombinant Human Thrombin (rhThrombin) Market Challenges
8.4 Recombinant Human Thrombin (rhThrombin) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Recombinant Human Thrombin (rhThrombin) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Recombinant Human Thrombin (rhThrombin) Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Recombinant Human Thrombin (rhThrombin) Market Competitive Situation by Manufacturers in 2024
Table 4. Global Recombinant Human Thrombin (rhThrombin) Sales (K Vitals) of Key Manufacturers (2020-2025)
Table 5. Global Recombinant Human Thrombin (rhThrombin) Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Recombinant Human Thrombin (rhThrombin) Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Recombinant Human Thrombin (rhThrombin) Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Recombinant Human Thrombin (rhThrombin) Average Price (US$/Vital) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Recombinant Human Thrombin (rhThrombin), Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Recombinant Human Thrombin (rhThrombin), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Recombinant Human Thrombin (rhThrombin), Product Type & Application
Table 12. Global Key Manufacturers of Recombinant Human Thrombin (rhThrombin), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Recombinant Human Thrombin (rhThrombin) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Thrombin (rhThrombin) as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Recombinant Human Thrombin (rhThrombin) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Recombinant Human Thrombin (rhThrombin) Sales by Region (2020-2025) & (K Vitals)
Table 18. Global Recombinant Human Thrombin (rhThrombin) Sales Market Share by Region (2020-2025)
Table 19. Global Recombinant Human Thrombin (rhThrombin) Sales by Region (2026-2031) & (K Vitals)
Table 20. Global Recombinant Human Thrombin (rhThrombin) Sales Market Share by Region (2026-2031)
Table 21. Global Recombinant Human Thrombin (rhThrombin) Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Recombinant Human Thrombin (rhThrombin) Revenue Market Share by Region (2020-2025)
Table 23. Global Recombinant Human Thrombin (rhThrombin) Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Recombinant Human Thrombin (rhThrombin) Revenue Market Share by Region (2026-2031)
Table 25. North America Recombinant Human Thrombin (rhThrombin) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Recombinant Human Thrombin (rhThrombin) Sales by Country (2020-2025) & (K Vitals)
Table 27. North America Recombinant Human Thrombin (rhThrombin) Sales by Country (2026-2031) & (K Vitals)
Table 28. North America Recombinant Human Thrombin (rhThrombin) Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Recombinant Human Thrombin (rhThrombin) Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Recombinant Human Thrombin (rhThrombin) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Recombinant Human Thrombin (rhThrombin) Sales by Country (2020-2025) & (K Vitals)
Table 32. Europe Recombinant Human Thrombin (rhThrombin) Sales by Country (2026-2031) & (K Vitals)
Table 33. Europe Recombinant Human Thrombin (rhThrombin) Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Recombinant Human Thrombin (rhThrombin) Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Recombinant Human Thrombin (rhThrombin) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Recombinant Human Thrombin (rhThrombin) Sales by Region (2020-2025) & (K Vitals)
Table 37. Asia Pacific Recombinant Human Thrombin (rhThrombin) Sales by Region (2026-2031) & (K Vitals)
Table 38. Asia Pacific Recombinant Human Thrombin (rhThrombin) Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Recombinant Human Thrombin (rhThrombin) Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Recombinant Human Thrombin (rhThrombin) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Recombinant Human Thrombin (rhThrombin) Sales by Country (2020-2025) & (K Vitals)
Table 42. Latin America Recombinant Human Thrombin (rhThrombin) Sales by Country (2026-2031) & (K Vitals)
Table 43. Latin America Recombinant Human Thrombin (rhThrombin) Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Recombinant Human Thrombin (rhThrombin) Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Recombinant Human Thrombin (rhThrombin) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Recombinant Human Thrombin (rhThrombin) Sales by Country (2020-2025) & (K Vitals)
Table 47. Middle East and Africa Recombinant Human Thrombin (rhThrombin) Sales by Country (2026-2031) & (K Vitals)
Table 48. Middle East and Africa Recombinant Human Thrombin (rhThrombin) Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Recombinant Human Thrombin (rhThrombin) Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Recombinant Human Thrombin (rhThrombin) Sales (K Vitals) by Type (2020-2025)
Table 51. Global Recombinant Human Thrombin (rhThrombin) Sales (K Vitals) by Type (2026-2031)
Table 52. Global Recombinant Human Thrombin (rhThrombin) Sales Market Share by Type (2020-2025)
Table 53. Global Recombinant Human Thrombin (rhThrombin) Sales Market Share by Type (2026-2031)
Table 54. Global Recombinant Human Thrombin (rhThrombin) Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Recombinant Human Thrombin (rhThrombin) Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Recombinant Human Thrombin (rhThrombin) Revenue Market Share by Type (2020-2025)
Table 57. Global Recombinant Human Thrombin (rhThrombin) Revenue Market Share by Type (2026-2031)
Table 58. Global Recombinant Human Thrombin (rhThrombin) Price (US$/Vital) by Type (2020-2025)
Table 59. Global Recombinant Human Thrombin (rhThrombin) Price (US$/Vital) by Type (2026-2031)
Table 60. Global Recombinant Human Thrombin (rhThrombin) Sales (K Vitals) by Application (2020-2025)
Table 61. Global Recombinant Human Thrombin (rhThrombin) Sales (K Vitals) by Application (2026-2031)
Table 62. Global Recombinant Human Thrombin (rhThrombin) Sales Market Share by Application (2020-2025)
Table 63. Global Recombinant Human Thrombin (rhThrombin) Sales Market Share by Application (2026-2031)
Table 64. Global Recombinant Human Thrombin (rhThrombin) Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Recombinant Human Thrombin (rhThrombin) Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Recombinant Human Thrombin (rhThrombin) Revenue Market Share by Application (2020-2025)
Table 67. Global Recombinant Human Thrombin (rhThrombin) Revenue Market Share by Application (2026-2031)
Table 68. Global Recombinant Human Thrombin (rhThrombin) Price (US$/Vital) by Application (2020-2025)
Table 69. Global Recombinant Human Thrombin (rhThrombin) Price (US$/Vital) by Application (2026-2031)
Table 70. Baxter Company Information
Table 71. Baxter Description and Business Overview
Table 72. Baxter Recombinant Human Thrombin (rhThrombin) Sales (K Vitals), Revenue (US$ Million), Price (US$/Vital) and Gross Margin (2020-2025)
Table 73. Baxter Recombinant Human Thrombin (rhThrombin) Product
Table 74. Baxter Recent Developments/Updates
Table 75. Suzhou Zelgen Biopharmaceuticals Company Information
Table 76. Suzhou Zelgen Biopharmaceuticals Description and Business Overview
Table 77. Suzhou Zelgen Biopharmaceuticals Recombinant Human Thrombin (rhThrombin) Sales (K Vitals), Revenue (US$ Million), Price (US$/Vital) and Gross Margin (2020-2025)
Table 78. Suzhou Zelgen Biopharmaceuticals Recombinant Human Thrombin (rhThrombin) Product
Table 79. Suzhou Zelgen Biopharmaceuticals Recent Developments/Updates
Table 80. Key Raw Materials Lists
Table 81. Raw Materials Key Suppliers Lists
Table 82. Recombinant Human Thrombin (rhThrombin) Distributors List
Table 83. Recombinant Human Thrombin (rhThrombin) Customers List
Table 84. Recombinant Human Thrombin (rhThrombin) Market Trends
Table 85. Recombinant Human Thrombin (rhThrombin) Market Drivers
Table 86. Recombinant Human Thrombin (rhThrombin) Market Challenges
Table 87. Recombinant Human Thrombin (rhThrombin) Market Restraints
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
Table 91. Authors List of This Report
List of Figures
Figure 1. Product Picture of Recombinant Human Thrombin (rhThrombin)
Figure 2. Global Recombinant Human Thrombin (rhThrombin) Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Recombinant Human Thrombin (rhThrombin) Market Share by Type: 2024 & 2031
Figure 4. 5,000 IU/Vital Product Picture
Figure 5. 20,000 IU/Vial Product Picture
Figure 6. Global Recombinant Human Thrombin (rhThrombin) Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Recombinant Human Thrombin (rhThrombin) Market Share by Application: 2024 & 2031
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Others
Figure 11. Global Recombinant Human Thrombin (rhThrombin) Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Recombinant Human Thrombin (rhThrombin) Market Size (2020-2031) & (US$ Million)
Figure 13. Global Recombinant Human Thrombin (rhThrombin) Sales (2020-2031) & (K Vitals)
Figure 14. Global Recombinant Human Thrombin (rhThrombin) Average Price (US$/Vital) & (2020-2031)
Figure 15. Recombinant Human Thrombin (rhThrombin) Report Years Considered
Figure 16. Recombinant Human Thrombin (rhThrombin) Sales Share by Manufacturers in 2024
Figure 17. Global Recombinant Human Thrombin (rhThrombin) Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Recombinant Human Thrombin (rhThrombin) Players: Market Share by Revenue in Recombinant Human Thrombin (rhThrombin) in 2024
Figure 19. Recombinant Human Thrombin (rhThrombin) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Recombinant Human Thrombin (rhThrombin) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Recombinant Human Thrombin (rhThrombin) Sales Market Share by Country (2020-2031)
Figure 22. North America Recombinant Human Thrombin (rhThrombin) Revenue Market Share by Country (2020-2031)
Figure 23. United States Recombinant Human Thrombin (rhThrombin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Recombinant Human Thrombin (rhThrombin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Recombinant Human Thrombin (rhThrombin) Sales Market Share by Country (2020-2031)
Figure 26. Europe Recombinant Human Thrombin (rhThrombin) Revenue Market Share by Country (2020-2031)
Figure 27. Germany Recombinant Human Thrombin (rhThrombin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Recombinant Human Thrombin (rhThrombin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Recombinant Human Thrombin (rhThrombin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Recombinant Human Thrombin (rhThrombin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Recombinant Human Thrombin (rhThrombin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Recombinant Human Thrombin (rhThrombin) Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Recombinant Human Thrombin (rhThrombin) Revenue Market Share by Region (2020-2031)
Figure 34. China Recombinant Human Thrombin (rhThrombin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Recombinant Human Thrombin (rhThrombin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Recombinant Human Thrombin (rhThrombin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Recombinant Human Thrombin (rhThrombin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Recombinant Human Thrombin (rhThrombin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Recombinant Human Thrombin (rhThrombin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Recombinant Human Thrombin (rhThrombin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Latin America Recombinant Human Thrombin (rhThrombin) Sales Market Share by Country (2020-2031)
Figure 42. Latin America Recombinant Human Thrombin (rhThrombin) Revenue Market Share by Country (2020-2031)
Figure 43. Mexico Recombinant Human Thrombin (rhThrombin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Brazil Recombinant Human Thrombin (rhThrombin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Argentina Recombinant Human Thrombin (rhThrombin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Colombia Recombinant Human Thrombin (rhThrombin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Recombinant Human Thrombin (rhThrombin) Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Recombinant Human Thrombin (rhThrombin) Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Recombinant Human Thrombin (rhThrombin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Recombinant Human Thrombin (rhThrombin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Recombinant Human Thrombin (rhThrombin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Recombinant Human Thrombin (rhThrombin) by Type (2020-2031)
Figure 53. Global Revenue Market Share of Recombinant Human Thrombin (rhThrombin) by Type (2020-2031)
Figure 54. Global Recombinant Human Thrombin (rhThrombin) Price (US$/Vital) by Type (2020-2031)
Figure 55. Global Sales Market Share of Recombinant Human Thrombin (rhThrombin) by Application (2020-2031)
Figure 56. Global Revenue Market Share of Recombinant Human Thrombin (rhThrombin) by Application (2020-2031)
Figure 57. Global Recombinant Human Thrombin (rhThrombin) Price (US$/Vital) by Application (2020-2031)
Figure 58. Recombinant Human Thrombin (rhThrombin) Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Recombinant Human Thrombin (rhThrombin) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Recombinant Human Thrombin (rhThrombin) Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Recombinant Human Thrombin (rhThrombin) Market Competitive Situation by Manufacturers in 2024
Table 4. Global Recombinant Human Thrombin (rhThrombin) Sales (K Vitals) of Key Manufacturers (2020-2025)
Table 5. Global Recombinant Human Thrombin (rhThrombin) Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Recombinant Human Thrombin (rhThrombin) Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Recombinant Human Thrombin (rhThrombin) Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Recombinant Human Thrombin (rhThrombin) Average Price (US$/Vital) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Recombinant Human Thrombin (rhThrombin), Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Recombinant Human Thrombin (rhThrombin), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Recombinant Human Thrombin (rhThrombin), Product Type & Application
Table 12. Global Key Manufacturers of Recombinant Human Thrombin (rhThrombin), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Recombinant Human Thrombin (rhThrombin) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Thrombin (rhThrombin) as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Recombinant Human Thrombin (rhThrombin) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Recombinant Human Thrombin (rhThrombin) Sales by Region (2020-2025) & (K Vitals)
Table 18. Global Recombinant Human Thrombin (rhThrombin) Sales Market Share by Region (2020-2025)
Table 19. Global Recombinant Human Thrombin (rhThrombin) Sales by Region (2026-2031) & (K Vitals)
Table 20. Global Recombinant Human Thrombin (rhThrombin) Sales Market Share by Region (2026-2031)
Table 21. Global Recombinant Human Thrombin (rhThrombin) Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Recombinant Human Thrombin (rhThrombin) Revenue Market Share by Region (2020-2025)
Table 23. Global Recombinant Human Thrombin (rhThrombin) Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Recombinant Human Thrombin (rhThrombin) Revenue Market Share by Region (2026-2031)
Table 25. North America Recombinant Human Thrombin (rhThrombin) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Recombinant Human Thrombin (rhThrombin) Sales by Country (2020-2025) & (K Vitals)
Table 27. North America Recombinant Human Thrombin (rhThrombin) Sales by Country (2026-2031) & (K Vitals)
Table 28. North America Recombinant Human Thrombin (rhThrombin) Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Recombinant Human Thrombin (rhThrombin) Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Recombinant Human Thrombin (rhThrombin) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Recombinant Human Thrombin (rhThrombin) Sales by Country (2020-2025) & (K Vitals)
Table 32. Europe Recombinant Human Thrombin (rhThrombin) Sales by Country (2026-2031) & (K Vitals)
Table 33. Europe Recombinant Human Thrombin (rhThrombin) Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Recombinant Human Thrombin (rhThrombin) Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Recombinant Human Thrombin (rhThrombin) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Recombinant Human Thrombin (rhThrombin) Sales by Region (2020-2025) & (K Vitals)
Table 37. Asia Pacific Recombinant Human Thrombin (rhThrombin) Sales by Region (2026-2031) & (K Vitals)
Table 38. Asia Pacific Recombinant Human Thrombin (rhThrombin) Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Recombinant Human Thrombin (rhThrombin) Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Recombinant Human Thrombin (rhThrombin) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Recombinant Human Thrombin (rhThrombin) Sales by Country (2020-2025) & (K Vitals)
Table 42. Latin America Recombinant Human Thrombin (rhThrombin) Sales by Country (2026-2031) & (K Vitals)
Table 43. Latin America Recombinant Human Thrombin (rhThrombin) Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Recombinant Human Thrombin (rhThrombin) Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Recombinant Human Thrombin (rhThrombin) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Recombinant Human Thrombin (rhThrombin) Sales by Country (2020-2025) & (K Vitals)
Table 47. Middle East and Africa Recombinant Human Thrombin (rhThrombin) Sales by Country (2026-2031) & (K Vitals)
Table 48. Middle East and Africa Recombinant Human Thrombin (rhThrombin) Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Recombinant Human Thrombin (rhThrombin) Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Recombinant Human Thrombin (rhThrombin) Sales (K Vitals) by Type (2020-2025)
Table 51. Global Recombinant Human Thrombin (rhThrombin) Sales (K Vitals) by Type (2026-2031)
Table 52. Global Recombinant Human Thrombin (rhThrombin) Sales Market Share by Type (2020-2025)
Table 53. Global Recombinant Human Thrombin (rhThrombin) Sales Market Share by Type (2026-2031)
Table 54. Global Recombinant Human Thrombin (rhThrombin) Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Recombinant Human Thrombin (rhThrombin) Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Recombinant Human Thrombin (rhThrombin) Revenue Market Share by Type (2020-2025)
Table 57. Global Recombinant Human Thrombin (rhThrombin) Revenue Market Share by Type (2026-2031)
Table 58. Global Recombinant Human Thrombin (rhThrombin) Price (US$/Vital) by Type (2020-2025)
Table 59. Global Recombinant Human Thrombin (rhThrombin) Price (US$/Vital) by Type (2026-2031)
Table 60. Global Recombinant Human Thrombin (rhThrombin) Sales (K Vitals) by Application (2020-2025)
Table 61. Global Recombinant Human Thrombin (rhThrombin) Sales (K Vitals) by Application (2026-2031)
Table 62. Global Recombinant Human Thrombin (rhThrombin) Sales Market Share by Application (2020-2025)
Table 63. Global Recombinant Human Thrombin (rhThrombin) Sales Market Share by Application (2026-2031)
Table 64. Global Recombinant Human Thrombin (rhThrombin) Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Recombinant Human Thrombin (rhThrombin) Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Recombinant Human Thrombin (rhThrombin) Revenue Market Share by Application (2020-2025)
Table 67. Global Recombinant Human Thrombin (rhThrombin) Revenue Market Share by Application (2026-2031)
Table 68. Global Recombinant Human Thrombin (rhThrombin) Price (US$/Vital) by Application (2020-2025)
Table 69. Global Recombinant Human Thrombin (rhThrombin) Price (US$/Vital) by Application (2026-2031)
Table 70. Baxter Company Information
Table 71. Baxter Description and Business Overview
Table 72. Baxter Recombinant Human Thrombin (rhThrombin) Sales (K Vitals), Revenue (US$ Million), Price (US$/Vital) and Gross Margin (2020-2025)
Table 73. Baxter Recombinant Human Thrombin (rhThrombin) Product
Table 74. Baxter Recent Developments/Updates
Table 75. Suzhou Zelgen Biopharmaceuticals Company Information
Table 76. Suzhou Zelgen Biopharmaceuticals Description and Business Overview
Table 77. Suzhou Zelgen Biopharmaceuticals Recombinant Human Thrombin (rhThrombin) Sales (K Vitals), Revenue (US$ Million), Price (US$/Vital) and Gross Margin (2020-2025)
Table 78. Suzhou Zelgen Biopharmaceuticals Recombinant Human Thrombin (rhThrombin) Product
Table 79. Suzhou Zelgen Biopharmaceuticals Recent Developments/Updates
Table 80. Key Raw Materials Lists
Table 81. Raw Materials Key Suppliers Lists
Table 82. Recombinant Human Thrombin (rhThrombin) Distributors List
Table 83. Recombinant Human Thrombin (rhThrombin) Customers List
Table 84. Recombinant Human Thrombin (rhThrombin) Market Trends
Table 85. Recombinant Human Thrombin (rhThrombin) Market Drivers
Table 86. Recombinant Human Thrombin (rhThrombin) Market Challenges
Table 87. Recombinant Human Thrombin (rhThrombin) Market Restraints
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
Table 91. Authors List of This Report
List of Figures
Figure 1. Product Picture of Recombinant Human Thrombin (rhThrombin)
Figure 2. Global Recombinant Human Thrombin (rhThrombin) Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Recombinant Human Thrombin (rhThrombin) Market Share by Type: 2024 & 2031
Figure 4. 5,000 IU/Vital Product Picture
Figure 5. 20,000 IU/Vial Product Picture
Figure 6. Global Recombinant Human Thrombin (rhThrombin) Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Recombinant Human Thrombin (rhThrombin) Market Share by Application: 2024 & 2031
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Others
Figure 11. Global Recombinant Human Thrombin (rhThrombin) Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Recombinant Human Thrombin (rhThrombin) Market Size (2020-2031) & (US$ Million)
Figure 13. Global Recombinant Human Thrombin (rhThrombin) Sales (2020-2031) & (K Vitals)
Figure 14. Global Recombinant Human Thrombin (rhThrombin) Average Price (US$/Vital) & (2020-2031)
Figure 15. Recombinant Human Thrombin (rhThrombin) Report Years Considered
Figure 16. Recombinant Human Thrombin (rhThrombin) Sales Share by Manufacturers in 2024
Figure 17. Global Recombinant Human Thrombin (rhThrombin) Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Recombinant Human Thrombin (rhThrombin) Players: Market Share by Revenue in Recombinant Human Thrombin (rhThrombin) in 2024
Figure 19. Recombinant Human Thrombin (rhThrombin) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Recombinant Human Thrombin (rhThrombin) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Recombinant Human Thrombin (rhThrombin) Sales Market Share by Country (2020-2031)
Figure 22. North America Recombinant Human Thrombin (rhThrombin) Revenue Market Share by Country (2020-2031)
Figure 23. United States Recombinant Human Thrombin (rhThrombin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Recombinant Human Thrombin (rhThrombin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Recombinant Human Thrombin (rhThrombin) Sales Market Share by Country (2020-2031)
Figure 26. Europe Recombinant Human Thrombin (rhThrombin) Revenue Market Share by Country (2020-2031)
Figure 27. Germany Recombinant Human Thrombin (rhThrombin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Recombinant Human Thrombin (rhThrombin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Recombinant Human Thrombin (rhThrombin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Recombinant Human Thrombin (rhThrombin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Recombinant Human Thrombin (rhThrombin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Recombinant Human Thrombin (rhThrombin) Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Recombinant Human Thrombin (rhThrombin) Revenue Market Share by Region (2020-2031)
Figure 34. China Recombinant Human Thrombin (rhThrombin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Recombinant Human Thrombin (rhThrombin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Recombinant Human Thrombin (rhThrombin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Recombinant Human Thrombin (rhThrombin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Recombinant Human Thrombin (rhThrombin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Recombinant Human Thrombin (rhThrombin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Recombinant Human Thrombin (rhThrombin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Latin America Recombinant Human Thrombin (rhThrombin) Sales Market Share by Country (2020-2031)
Figure 42. Latin America Recombinant Human Thrombin (rhThrombin) Revenue Market Share by Country (2020-2031)
Figure 43. Mexico Recombinant Human Thrombin (rhThrombin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Brazil Recombinant Human Thrombin (rhThrombin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Argentina Recombinant Human Thrombin (rhThrombin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Colombia Recombinant Human Thrombin (rhThrombin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Recombinant Human Thrombin (rhThrombin) Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Recombinant Human Thrombin (rhThrombin) Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Recombinant Human Thrombin (rhThrombin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Recombinant Human Thrombin (rhThrombin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Recombinant Human Thrombin (rhThrombin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Recombinant Human Thrombin (rhThrombin) by Type (2020-2031)
Figure 53. Global Revenue Market Share of Recombinant Human Thrombin (rhThrombin) by Type (2020-2031)
Figure 54. Global Recombinant Human Thrombin (rhThrombin) Price (US$/Vital) by Type (2020-2031)
Figure 55. Global Sales Market Share of Recombinant Human Thrombin (rhThrombin) by Application (2020-2031)
Figure 56. Global Revenue Market Share of Recombinant Human Thrombin (rhThrombin) by Application (2020-2031)
Figure 57. Global Recombinant Human Thrombin (rhThrombin) Price (US$/Vital) by Application (2020-2031)
Figure 58. Recombinant Human Thrombin (rhThrombin) Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global White Oil Market Research Report 2025
Aug 11, 25
Global Piezo Materials Market Research Report 2025
Aug 11, 25
Global Piezoceramic Materials Market Research Report 2025
Aug 11, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232